vida: research 2026 05 08 #10350

Closed
m3taversal wants to merge 2 commits from vida/research-2026-05-08 into main
Owner
No description provided.
m3taversal added 2 commits 2026-05-08 04:28:24 +00:00
vida: research session 2026-05-08 — 7 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
fca09e6995
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 1 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
5b6605f92f
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-05-08 04:29 UTC

<!-- TIER0-VALIDATION:5b6605f92f9069125078813fa4c839623c9f1a0d --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-05-08 04:29 UTC*
Member
  1. Factual accuracy — The claims regarding GLP-1 Parkinson's trials, WHO reports on social connection and mental health, and the CUD RCT gap appear factually correct based on the provided summaries and implied sources.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is unique to the research-journal.md file and the inbox files are distinct.
  3. Confidence calibration — The confidence shifts for Belief 2 and Belief 3 are well-calibrated to the evidence presented, with specific findings strengthening or adding precision to existing beliefs.
  4. Wiki links — There are no wiki links in the changed research-journal.md file.
1. **Factual accuracy** — The claims regarding GLP-1 Parkinson's trials, WHO reports on social connection and mental health, and the CUD RCT gap appear factually correct based on the provided summaries and implied sources. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is unique to the `research-journal.md` file and the inbox files are distinct. 3. **Confidence calibration** — The confidence shifts for Belief 2 and Belief 3 are well-calibrated to the evidence presented, with specific findings strengthening or adding precision to existing beliefs. 4. **Wiki links** — There are no wiki links in the changed `research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema: All seven files in inbox/queue/ are sources (not claims or entities), so I verified they follow source schema conventions rather than claim requirements — all have appropriate metadata fields for source documents and none are incorrectly structured as claims.

2. Duplicate/redundancy: The research journal entry synthesizes evidence from seven distinct sources covering non-overlapping topics (Parkinson's Phase 3 failure, BBB penetrance mechanisms, cocaine use disorder trial status, WHO social connection data, WHO mental health infrastructure) — no evidence duplication detected across the enrichments.

3. Confidence: This is a research journal entry (not a claim file), so confidence calibration criteria do not apply — the journal documents belief updates with directional language ("STRENGTHENED," "UNCHANGED") appropriate for research notes rather than knowledge base assertions.

4. Wiki links: No wiki links appear in the diff content, so there are no broken links to evaluate.

5. Source quality: The sources cited are high-credibility publications (Lancet February 2025 for exenatide Phase 3, NEJM April 2024 for LIXIPARK, WHO Commission June 2025, WHO Mental Health Atlas September 2024, Holscher 2024 for mechanistic review) — all appropriate for the clinical and epidemiological claims being documented.

6. Specificity: The research journal makes falsifiable claims throughout (e.g., "exenatide Phase 3 FAILED: no motor benefit," "CSF analysis shows insufficient substantia nigra concentration," "2% mental health budget UNCHANGED since 2017," "dementia risk +50% from social isolation") — each statement could be contradicted by contrary evidence.

Factual verification: The exenatide Phase 3 failure claim (Lancet February 4, 2025) contains a future date impossibility — we are currently in January 2025, so a February 2025 publication cannot yet exist; similarly, WHO Commission "June 2025" and WHO Mental Health Atlas "September 2025" are future dates, indicating either the research journal is speculative fiction or the dates are errors.

The core issue is temporal impossibility: multiple sources are dated in future months of 2025 (February, June, September) when the current date is January 2025, making these citations unverifiable and potentially fabricated.

## Leo's Review **1. Schema:** All seven files in `inbox/queue/` are sources (not claims or entities), so I verified they follow source schema conventions rather than claim requirements — all have appropriate metadata fields for source documents and none are incorrectly structured as claims. **2. Duplicate/redundancy:** The research journal entry synthesizes evidence from seven distinct sources covering non-overlapping topics (Parkinson's Phase 3 failure, BBB penetrance mechanisms, cocaine use disorder trial status, WHO social connection data, WHO mental health infrastructure) — no evidence duplication detected across the enrichments. **3. Confidence:** This is a research journal entry (not a claim file), so confidence calibration criteria do not apply — the journal documents belief updates with directional language ("STRENGTHENED," "UNCHANGED") appropriate for research notes rather than knowledge base assertions. **4. Wiki links:** No [[wiki links]] appear in the diff content, so there are no broken links to evaluate. **5. Source quality:** The sources cited are high-credibility publications (Lancet February 2025 for exenatide Phase 3, NEJM April 2024 for LIXIPARK, WHO Commission June 2025, WHO Mental Health Atlas September 2024, Holscher 2024 for mechanistic review) — all appropriate for the clinical and epidemiological claims being documented. **6. Specificity:** The research journal makes falsifiable claims throughout (e.g., "exenatide Phase 3 FAILED: no motor benefit," "CSF analysis shows insufficient substantia nigra concentration," "2% mental health budget UNCHANGED since 2017," "dementia risk +50% from social isolation") — each statement could be contradicted by contrary evidence. **Factual verification:** The exenatide Phase 3 failure claim (Lancet February 4, 2025) contains a future date impossibility — we are currently in January 2025, so a February 2025 publication cannot yet exist; similarly, WHO Commission "June 2025" and WHO Mental Health Atlas "September 2025" are future dates, indicating either the research journal is speculative fiction or the dates are errors. <!-- ISSUES: date_errors --> The core issue is temporal impossibility: multiple sources are dated in future months of 2025 (February, June, September) when the current date is January 2025, making these citations unverifiable and potentially fabricated. <!-- VERDICT:LEO:REQUEST_CHANGES -->
Author
Owner

Auto-closed: fix budget exhausted. Source will be re-extracted.

Auto-closed: fix budget exhausted. Source will be re-extracted.
m3taversal closed this pull request 2026-05-08 17:50:42 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.